132 related articles for article (PubMed ID: 923041)
1. Effect of methylprednisolone upon technetium-99m pyrophosphate assessment myocardial necrosis in the canine countershock model.
Schneider RM; Hayslett JP; Downing SE; Berger HJ; Donabedian RK; Zaret BL
Circulation; 1977 Dec; 56(6):1029-34. PubMed ID: 923041
[TBL] [Abstract][Full Text] [Related]
2. Myocsrdial uptake of technetium-99m stannous pyrophosphate following direct current transthoracic countershock.
DiCola VC; Freedman GS; Downing SE; Zaret BL
Circulation; 1976 Dec; 54(6):980-6. PubMed ID: 991415
[TBL] [Abstract][Full Text] [Related]
3. Dual radionuclide study of myocardial infarction. Relationships between myocardial uptake of potassium-43, technetium-99m stannous pyrophosphate, regional myocardial blood flow and creatine phosphokinase depletion.
Zaret B; DiCola VC; Donabedian RK; Puri S; Wolfson S; Freedman GS; Cohen LS
Circulation; 1976 Mar; 53(3):422-8. PubMed ID: 174835
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-pyrophosphate uptake as an indicator of myocardial injury without infarct.
Okuda K; Nohara R; Fujita M; Tamaki N; Konishi J; Sasayama S
J Nucl Med; 1994 Aug; 35(8):1366-70. PubMed ID: 8046495
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy.
Poliner LR; Buja LM; Parkey RW; Bonte FJ; Willerson JT
Circulation; 1979 Feb; 59(2):257-67. PubMed ID: 758994
[TBL] [Abstract][Full Text] [Related]
6. Cardioversion and "false positive" technetium-99m stannous pyrophosphate myocardial scintigrams.
Pugh BR; Buja LM; Parkey RW; Poliner LR; Stokely EM; Bonte FJ; Willerson JT
Circulation; 1976 Sep; 54(3):399-403. PubMed ID: 181172
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.
Willerson JT; Parkey RW; Bonte FJ; Lewis SE; Corbett J; Buja LM
Semin Nucl Med; 1980 Jan; 10(1):54-69. PubMed ID: 6246640
[TBL] [Abstract][Full Text] [Related]
8. Value and limitations of technetium-99m stannous pyrophosphate in the detection of acute myocardial infarction.
Codini MA; Turner DA; Battle WE; Hassan P; Ali A; Messer JV
Am Heart J; 1979 Dec; 98(6):752-62. PubMed ID: 495427
[TBL] [Abstract][Full Text] [Related]
9. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
10. Assessment of acute myocardial necrosis after cardiopulmonary resuscitation and cardioversion by means of combined thallium-201/technetium-99m pyrophosphate tomography.
Krause T; Hohnloser SH; Kasper W; Schümichen C; Reinhardt M; Moser E
Eur J Nucl Med; 1995 Nov; 22(11):1286-91. PubMed ID: 8575479
[TBL] [Abstract][Full Text] [Related]
11. Morphologic correlates of technetium-99m stannous pyrophosphate imaging of acute myocardial infarcts in dogs.
Buja LM; Parkey RW; Dees JH; Stokely EM; Harris RA; Bonte FJ; Willerson JT
Circulation; 1975 Oct; 52(4):596-607. PubMed ID: 168990
[TBL] [Abstract][Full Text] [Related]
12. Postcountershock myocardial damage after pretreatment with adrenergic and calcium channel antagonists in halothane-anesthetized dogs.
Gaba DM; Metz S; Maze M
Anesthesiology; 1985 May; 62(5):610-4. PubMed ID: 3994026
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs.
Buja LM; Parkey RW; Stokely EM; Bonte FJ; Willerson JT
J Clin Invest; 1976 Jun; 57(6):1508-22. PubMed ID: 180053
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m stannous pyrophosphate "hot spot" imaging to detect acute myocardial infarcts.
Willerson JT; Parkey RW; Buja LM; Bonte FJ
Cardiovasc Clin; 1979; 10(2):139-48. PubMed ID: 487370
[No Abstract] [Full Text] [Related]
15. Noninvasive quantitation of myocardial infarction with technetium 99m pyrophosphate.
Botvinick EH; Shames D; Lappin H; Tyberg JV; Townsend R; Parmley WW
Circulation; 1975 Nov; 52(5):909-15. PubMed ID: 170018
[TBL] [Abstract][Full Text] [Related]
16. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate.
Jansen DE; Corbett JR; Buja LM; Hansen C; Ugolini V; Parkey RW; Willerson JT
Circulation; 1987 Mar; 75(3):611-7. PubMed ID: 3493088
[TBL] [Abstract][Full Text] [Related]
17. Relationships between myocardial perfusion, myocardial necrosis, and technetium--99m pyrophosphate uptake in dogs subjected to sudden coronary occlusion.
Marcus ML; Tomanek RJ; Ehrhardt JC; Kerber RE; Brown DD; Abboud FM
Circulation; 1976 Oct; 54(4):647-53. PubMed ID: 183915
[TBL] [Abstract][Full Text] [Related]
18. A computer-based scintigraphic method for sizing acute inferior myocardial infarcts.
Lewis MH; Buja LM; Parkey RW; Mishelevich DJ; Bonte FJ; Saffer SI; Richmond JR; Willerson JT
Radiology; 1980 Aug; 136(2):439-42. PubMed ID: 7403522
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms contributing to myocardial accumulation of technetium-99m stannous pyrophosphate after coronary arterial occlusion.
Coleman RE; Klein MS; Ahmed SA; Weiss ES; Buchholz WM; Sobel BE
Am J Cardiol; 1977 Jan; 39(1):55-9. PubMed ID: 188332
[TBL] [Abstract][Full Text] [Related]
20. [Estimate of the size of acute myocardial infarct by creatine kinase and cardiac gammagraphy with PyP-Sn-Tc99m. Study of their correlations and of the usefulness of a single determination of creatine kinase 20 hours later].
Suárez Pinilla MA; Cía P; Civeira Otermin F; Rodrigo G; Millastre A; Carreras JL; Andreo P
Rev Esp Cardiol; 1983; 36(5):383-90. PubMed ID: 6669784
[No Abstract] [Full Text] [Related]
[Next] [New Search]
